Previous 10 | Next 10 |
CymaBay Therapeutics (NASDAQ: CBAY ) -75% on halting trial of seladelpar. More news on: CymaBay Therapeutics, Inc., Adamis Pharmaceuticals Corporation, La Jolla Pharmaceutical Company, Stocks on the move, Read more ...
These Penny Stocks Raced Higher On Friday But Can They Maintain The Trend Next Week? After all of the major markets took a slight dip yesterday, they all seem to be in the green to start off November 22nd’s trading session. It is a strong look for the markets to show some corrections an...
Aslan Pharmaceuticals ( ASLN +388.7% ) skyrockets on news that new pre-clinical data characterizing its ASLAN003 drug as a potential treatment for acute myeloid leukemia was published in the latest Haematologica Journal . More news on: ASLAN Pharmaceuticals Limited, Healthcare stocks ...
SINGAPORE, Nov. 22, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that new preclinical data characterising ASLAN003 as a potential treatment for acute myeloid leukaemia (AML) has b...
BeiGene (BGNE) [HK:06160], a Beijing oncology biopharma, announced US approval of its Bruton's tyrosine kinase candidate, Brukinsa™ (zanubrutinib), as a second-line treatment for adult patients with mantle cell lymphoma (see story ). Brukinsa is the first BeiGene-discovered product to ...
Thinly traded nano cap ASLAN Pharmaceuticals ( ASLN -56.2% ) craters on almost a 5x surge in volume, albeit on turnover of only 106K shares, in reaction to unsuccessful results from the first part of its Phase 2/3 clinical trial, TreeTopp , evaluating lead candidate varlitinib in patien...
- The study did not meet its co-primary endpoints. The primary analysis of PFS yielded a hazard ratio of 0.90 in favour of varlitinib , and the ORR for varlitinib was 9.4% versus 4.8% in the control arm. These were not significant at the pre-specified levels - Varlitinib was gene...
Gainers: Constellation Pharmaceuticals (NASDAQ: CNST ) +99% . More news on: Constellation Pharmaceuticals, Inc., FuelCell Energy, Inc., comScore, Inc., Stocks on the move, Read more ...
ASLAN Pharmaceuticals (NASDAQ: ASLN ) has issued a registration to offer $100M in shares. More news on: ASLAN Pharmaceuticals Limited, Healthcare stocks news, Global news and forex, Read more ...
ASLAN Pharmaceuticals (NASDAQ: ASLN ): Q3 GAAP EPS of -$0.03 beats by $0.20 . More news on: ASLAN Pharmaceuticals Limited, Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
ASLAN Pharmaceuticals Limited Company Name:
ASLN Stock Symbol:
NASDAQ Market:
Morgan Advanced Materials Plc (MCRUF) is expected to report for Q4 2023 Security Federal Corp (SFDL) is expected to report for Q1 2024 Bank of the James Financial Group Inc. (BOTJ) is expected to report for Q1 2024 OMV AG (OMVJF) is expected to report $1.91 for Q1 2024 Pola Orbis ...
SAN MATEO, Calif. and SINGAPORE, April 24, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN), a clinical-stage, immunology-focused bi...
SAN MATEO, Calif. and SINGAPORE, April 24, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that an abstract on eblasakimab in Chro...